suchit_bhavsar
★    

India,
2013-04-23 13:39
(4802 d 10:41 ago)

Posting: # 10470
Views: 5,585
 

 Protocol amendment [Study Per­for­mance]

Hello to all,

Can I have your views, regarding the following situation:

In BA/BE study, amendment is taken e.g for study design, Change in reference medicinal product etc. all this things can change the title of the protocol.

So what will be the protocol title in "Under taking by the Investigator", study report, FDA form 3455, FDA form 1572, randomization etc.


Regards,
Suchit Bhavsar
drgunasakaran1
★★  
avatar

2013-04-23 18:19
(4802 d 06:01 ago)

@ suchit_bhavsar
Posting: # 10474
Views: 4,356
 

 Protocol amendment

Dear Mr Suchit Bhavsar,

❝ In BA/BE study, amendment is taken e.g for study design, Change in reference medicinal product etc. all this things can change the title of the protocol.


It is preferable to change the version of the protocol if you change the study design and reference medicinal product and capture the Title of the new version of protocol along with version number in the Under taking by the Investigator, study report, FDA form 3455, FDA form 1572, randomization etc.,

If you are planning to raise protocol amendment only, then the Amended Study Title should be provided in the Under taking by the Investigator", study report, FDA form 3455, FDA form 1572, randomization etc

Dr Gunasakaran Sambandan MD
Disclaimer: The replies/posts are my personal opinions, and they do not represent my company's views on the same. LinkedIn
UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
113 visitors (0 registered, 113 guests [including 7 identified bots]).
Forum time: 00:21 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5